Aclidinium bromide/formoterol

Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD).^[5] It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β₂ agonist.^[3][4]

Aclidinium bromide/formoterol

Combination of
Aclidinium bromide	Long-acting muscarinic antagonist
Formoterol	Long-acting β2 agonist
Clinical data
Trade names	Brimica Genuair, Duaklir Genuair, Duaklir Pressair
AHFS/Drugs.com	Professional Drug Facts
License data	US DailyMed: Duaklir
Pregnancy category	AU: B3
Routes of administration	Inhalation
ATC code	R03AL05 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) UK: POM (Prescription only)[1] US: ℞-only[2] EU: Rx-only[3][4] In general: ℞ (Prescription only)
Identifiers
CAS Number	2446159-07-3
KEGG	D11857